P-Glycoprotein Expression and Regulation: Age-Related Changes and Potential Effects on Drug Therapy

Drugs & Aging

Volumn 7, Issue 1, 1995, Pages 19-29

  Gupta, Sudhir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; RNA;

AGING; B LYMPHOCYTE; BIOSYNTHESIS; CYTOLOGY; DRUG THERAPY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MONOCYTE; MULTIDRUG RESISTANCE; NATURAL KILLER CELL; REVIEW; T LYMPHOCYTE;

AGING; B-LYMPHOCYTES; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY; GENE EXPRESSION REGULATION; HUMAN; IMMUNE SYSTEM; KILLER CELLS, NATURAL; MONOCYTES; P-GLYCOPROTEIN; RNA; T-LYMPHOCYTES;

EID: 0029337445     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/00002512-199507010-00003     Document Type: Review

References (81)

1. P-glycoprotein: multidrug resistance and a superfamily of membrane associated transport protein
2. The role of MDR-1 (P-glycoprotein) gene in multiple drug resistance in vitro and in vivo
3. Biochemistry of multidrug resistance mediated by the multidrug transporter
4. Multidrug resistance: a novel class of membrane-associated transport proteins is identified
5. ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance
6. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins
7. Internal duplication and homology with bacterial transport proteins in the mdr 1 (P-glycoprotein) gene from multidrug resistant human cells
8. The CF gene product as a member of a membrane transporter (TM6-NBF) super family
9. Overexpression of a transporter gene in a multidrug-resistant human cancer cell line
10. The multidrug resistance (mdr1) gene product functions as an ATP channel
11. Structural model of ATP-binding protein associated with cystic fibrosis, multidrug resistance and bacterial transport
12. Human P-glycoprotein transports Cortisol, aldosterone, and dexamethasone, but not progesterone
13. Peptide transport by the multidrug resistance pump
14. The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin
15. Characterization of multidrug resistance by fluorescent dyes
16. Amplification of multidrug resistant gene in some chloroquine-resistant isolates of P. falciparum
17. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum
18. Human immunodeficiency virus 1 (HIV-l) -induced P-glycoprotein expression
19. Resistance to AZT might also involve the cellular expression of multidrug resistance by P-glycoprotein
20. Apparent stronger expression in the human adrenal cortex than in human adrenal medulla of Mr 170,000–180,000 P-glycoprotein
21. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
22. Tissue distribution of P-glycoprotein encoded by a multidrug resistance gene as revealed by a monoclonal antibodies MRK-16
23. Expression of a multidrug resistance gene in human tumors and tissues
24. Cellular localization of multidrug resistance gene product P-glycoprotein in normal human tissues
25. Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood brain barrier sites
26. P-glycoprotein (MDR 1 gene product) in cells of the immune system: its possible role physiologic and alteration in aging and human immunodeficiency virus-1 infection
27. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function
28. Expression of multidrug resistance gene 1 (mdr 1) in human T cell subsets: regulation by cyclosporin A and role of protein kinase C isoforms
29. Expression, regulation, and function of multidrug resistant gene 1 product (P-glycoprotein), a metabolic and functional transport pump in human T cells
30. Mdr 1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral and umbilical cord blood
31. Multidrug resistance activity in human lymphocytes
32. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells
33. P-glycoprotein expression and function in circulating blood cells from normal volunteers
34. Expression of multidrug resistance gene (MDR-1) in human normal leukocytes
35. Flow cytometric analysis of P-glycoprotein in normal and leukemic cells
36. P-glycoprotein expression in normal and reactive bone marrows
37. Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells
38. Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation
39. Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody
40. Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine
41. Characterization of the azidopine and vinblastine binding site of P-glycoprotein
42. Localization of multidrug resistance-associated DNA sequences to human chromosome 7
43. Localization of the human multiple drug resistance gene, MDR1, to 7q21.1
44. Structure and expression of the human MDR (P-glycoprotein) gene family
45. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins
46. Mammalian multidrug-resistance gene: correlation of exon organization with structural domains and duplication of an ancestral gene
47. Expression of the mdr-l/P-170 gene in patients with acute lymphoblastic leukemia
48. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene
49. Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr la reveal a negative element containing the AP-1 binding site
50. The human multidrug resistance gene: sequences upstream and downstream of the initiation site influence transcription
51. Modulation of drug permeability in Chinese hamster ovary cells. Possible role for phosphorylation of surface glycoproteins
52. Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: effects of verapamil, trifluoperazine, and phorbol esters
53. Phosphorylation of the multidrug resistance associated glycoprotein
54. Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells
55. Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues
56. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells
57. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus
58. Cyclic AMP-dependent protein kinase regulates sensitivity of cells to multiple drugs
59. Identification of multidrug resistance related P-glycoprotein as a cyclosporin binding protein
60. Human P-glycoprotein transports cyclosporin A and FK506
61. Multidrug resistant phenotype of a subpopulation of T lymphocytes without drug selection
62. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype
63. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes
64. Age-related changes in human lymphocyte subsets: progressive reduction of the CD4CD45R (suppressor inducer) population
65. hiCD4+ T cells
66. α1 integrin (CD29) expression on human postnatal T cell subsets defined by selective CD45 isoform expression
67. Increased function of P-glycoprotein in T lymphocyte subsets of aging mice
68. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein
69. Membrane signal transduction in T cells in aging humans
70. Dysregulated production of cytokines by CD4+ T cell subsets from aging humans
71. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53
72. Kinetics of cellular oncogene expression in mouse lymphocytes: I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens
73. Role of oncogenes in the regulation of MHC antigen expression
74. Expression, methylation and chromatin structure of the p53 gene in untransformed and human T-cell leukemia virus type 1-transformed human T-lymphocytes
75. Biology of natural killer cells
76. Resistance to natural killer cell-mediated cytolysis by pleiotropic drug-resistant human erythroleukemia (K-562R) cell line
77. Diverse multidrug-resistance-modifying agents inhibit cytolytic activity of natural killer cells
78. Resistance of multidrug resistant cell lines to natural killer-like cell-mediated cytotoxicity
79. Susceptibility of multidrug-resistant human leukemic cell lines to human inter-leukin 2-activated killer cells
80. Transport protein genes in the murine MHC: possible implications for antigen processing
81. Stimulation of interleukin 1α secretion in monkey kidney cells by coexpression of the mammalian P-glycoprotein MDR 1